Inspire Medical Systems Statistics
Share Statistics
Inspire Medical Systems has 29.97M shares outstanding. The number of shares has increased by 1.01% in one year.
| Shares Outstanding | 29.97M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.37% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 29.40M |
| Failed to Deliver (FTD) Shares | 20 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.95M, so 6.52% of the outstanding shares have been sold short.
| Short Interest | 1.95M |
| Short % of Shares Out | 6.52% |
| Short % of Float | 6.65% |
| Short Ratio (days to cover) | 5.07 |
Valuation Ratios
The PE ratio is -281.8 and the forward PE ratio is 96.34.
| PE Ratio | -281.8 |
| Forward PE | 96.34 |
| PS Ratio | 9.54 |
| Forward PS | 5.9 |
| PB Ratio | 10.41 |
| P/FCF Ratio | 5821.23 |
| PEG Ratio | n/a |
Enterprise Valuation
Inspire Medical Systems Inc. has an Enterprise Value (EV) of 5.80B.
| EV / Earnings | -274.2 |
| EV / Sales | 9.28 |
| EV / EBITDA | -339.99 |
| EV / EBIT | -144.03 |
| EV / FCF | 5664.3 |
Financial Position
The company has a current ratio of 7.6, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.6 |
| Quick Ratio | 7.17 |
| Debt / Equity | 0.04 |
| Total Debt / Capitalization | 4.16 |
| Cash Flow / Debt | 0.99 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.04% and return on capital (ROIC) is -7.16%.
| Return on Equity (ROE) | -0.04% |
| Return on Assets (ROA) | -0.03% |
| Return on Capital (ROIC) | -7.16% |
| Revenue Per Employee | 618.00K |
| Profits Per Employee | -20.92K |
| Employee Count | 1.01K |
| Asset Turnover | 0.92 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | 1.25M |
| Effective Tax Rate | -0.06 |
Stock Price Statistics
The stock price has increased by 0.18% in the last 52 weeks. The beta is 1.36, so Inspire Medical Systems 's price volatility has been higher than the market average.
| Beta | 1.36 |
| 52-Week Price Change | 0.18% |
| 50-Day Moving Average | 195.05 |
| 200-Day Moving Average | 186.69 |
| Relative Strength Index (RSI) | 48.71 |
| Average Volume (20 Days) | 564.43K |
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of $624.80M and earned -$21.15M in profits. Earnings per share was $-0.72.
| Revenue | 624.80M |
| Gross Profit | 528.22M |
| Operating Income | -40.27M |
| Net Income | -21.15M |
| EBITDA | -17.06M |
| EBIT | -40.27M |
| Earnings Per Share (EPS) | -0.72 |
Balance Sheet
The company has $185.54M in cash and $24.85M in debt, giving a net cash position of $160.69M.
| Cash & Cash Equivalents | 185.54M |
| Total Debt | 24.85M |
| Net Cash | 160.69M |
| Retained Earnings | -345.42M |
| Total Assets | 796.19M |
| Working Capital | 508.26M |
Cash Flow
In the last 12 months, operating cash flow was $24.65M and capital expenditures -$23.63M, giving a free cash flow of $1.02M.
| Operating Cash Flow | 24.65M |
| Capital Expenditures | -23.63M |
| Free Cash Flow | 1.02M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 84.54%, with operating and profit margins of -6.45% and -3.39%.
| Gross Margin | 84.54% |
| Operating Margin | -6.45% |
| Pretax Margin | -3.19% |
| Profit Margin | -3.39% |
| EBITDA Margin | -2.73% |
| EBIT Margin | -6.45% |
| FCF Margin | 0.16% |
Dividends & Yields
INSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.38% |
| FCF Yield | 0.02% |
Analyst Forecast
The average price target for INSP is $240, which is 27.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $240 |
| Price Target Difference | 27.4% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Scores
| Altman Z-Score | 36.01 |
| Piotroski F-Score | 6 |